Structurally and functionally distinct early antibody responses predict COVID-19 disease trajectory and mRNA vaccine response.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
27 Dec 2021
Historique:
pubmed: 3 6 2021
medline: 3 6 2021
entrez: 2 6 2021
Statut: epublish

Résumé

A damaging inflammatory response is strongly implicated in the pathogenesis of severe COVID-19 but mechanisms contributing to this response are unclear. In two prospective cohorts, early non-neutralizing, afucosylated, anti-SARS-CoV-2 IgG predicted progression from mild, to more severe COVID-19. In contrast to the antibody structures that predicted disease progression, antibodies that were elicited by mRNA SARS-CoV-2 vaccines were low in Fc afucosylation and enriched in sialylation, both modifications that reduce the inflammatory potential of IgG. To study the biology afucosylated IgG immune complexes, we developed an Divergent early antibody responses predict COVID-19 disease trajectory and mRNA vaccine response and are functionally distinct

Identifiants

pubmed: 34075376
doi: 10.1101/2021.05.25.445649
pmc: PMC8168384
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIAID NIH HHS
ID : K23 AI127886
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI150741
Pays : United States

Auteurs

Classifications MeSH